MoviePass competitor Sinemia unveils plans starting at $4.99 a month

Olive Hawkins
May 5, 2018

On Friday, Sinemia revealed that it was splitting its service into four separate tiers, starting at $4.99 for one movie ticket per month. For example, even though monthly subscriptions are per ticket, their users can watch 3D, 4D, and IMAX movies, while that is not the case with MoviePass. "We believe the only way to accomplish this is through a sustainable movie subscription model". Sinemia's app and card operate in such a similar fashion that they infringe on the patents, MoviePass argues.

For $4.99 per month, customers can get one movie ticket per month to any 2-D feature film while $6.99 gets them two tickets per month.

The service's movie-a-day deal remains popular among moviegoers.

MoviePass has exploded in popularity, going from 12,000 to 1.5 million in the course of five months, according to the suit.

Wall Street opens lower after USA jobs data
Cardinal said its Cordis cardiovascular products business ran into supply chain problems and also paid a higher expected tax rate. Stocks recorded large swings during the session amid uncertainty over the outcome of trade talks between the USA and China.

Samsung Galaxy C7 Pro Gets Price Cut of Rs 2.500
In a world of data breaches and hacks, the thought of having a phone that is totally secure is most certainly appealing. The new set of renders appear to be for the official cases that will be offered for these devices.

CVS Health (NYSE:CVS) Given a $85.00 Price Target at Leerink Swann
State Of Alaska Department Of Revenue holds 0.18% of its portfolio in CVS Health Corporation ( NYSE : CVS ) for 101,835 shares. The stock of CVS Health Corporation ( NYSE : CVS ) earned "Buy" rating by RBC Capital Markets on Monday , December 4.

For those of you out of the loop, MoviePass and Sinemia are both subscription services for movie tickets. But with MoviePass, you could theoretically see 30 movies in theaters for about $10 a month, so for heavy moviegoers it's quite a different value proposition. For years, Sinemia has been available in other parts of the world like the United Kingdom, Canada, Turkey, and Australia.

Sinemia says its service can be used at all major theater chains and for advanced seating and seat selections (unlike MoviePass).

Though a solid business model is still unclear, expect to see more companies jump in this space and try to figure it out.

Other reports by

Discuss This Article

FOLLOW OUR NEWSPAPER